Purchase Order 75N92024P00222
Award Date 7/11/24
Potential Completion Date 10/10/24
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60637, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $21,666.00 firm fixed price purchase order contract to The University of Chicago Medical Center, doing business as Bernard Mitchell Hospital, for a Hereditary Myeloid Malignancy Panel. The contract has an ultimate completion date of October 10, 2024 and was awarded on July 11, 2024. The University of Chicago Medical Center is a non-profit academic health...
- The National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, has awarded a $23,774.00 Firm Fixed Price Purchase Order to The University of Chicago Medical Center, doing business as Bernard Mitchell Hospital, a non-profit academic health system. The contract is for a "Hereditary Myeloid Malignancy Panel" and has an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. The University of...
- This is a $24,564 firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to The University of Chicago Medical Center (doing business as Bernard Mitchell Hospital). The contract is for the provision of comprehensive IBMF sequencing panels, which support clinical decision-making for patients, including choices related to bone marrow transplant donors and immunosuppression...
- The U.S. National Heart Lung and Blood Institute (NHLBI) awarded a $21,529 firm fixed-price purchase order to The University of Chicago Medical Center, doing business as Bernard Mitchell Hospital, for a Hereditary Myeloid Malignancy Panel. This non-set-aside contract has a period of performance through October 10, 2024. The University of Chicago Medical Center is a non-profit academic health system that has also received federal grants, including a $2.5 million project grant from the Substance...
- The National Heart Lung and Blood Institute, a civilian federal agency, awarded a $14,832 firm-fixed-price purchase order to the University of Chicago Medical Center, doing business as Bernard Mitchell Hospital, to deliver a Hereditary Myeloid Malignancy Panel. The award has an ultimate completion date of October 10, 2024. The University of Chicago Medical Center is a non-profit academic health system that has also received grants and subawards from the Department of Health and Human Services,...
- The National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $21,012 Firm Fixed Price Purchase Order to The University of Chicago Medical Center, doing business as Bernard Mitchell Hospital, a non-profit health system. The contract is for the provision of a myeloid malignancy sequencing panel to support clinical decision-making related to bone marrow transplant donor selection and immunosuppression treatment for patients seen...
- The U.S. National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, has awarded a $12,360 firm-fixed-price purchase order to the University of Chicago Medical Center (dba Bernard Mitchell Hospital). The contract is for the provision of a myeloid malignancy sequencing panel, which is required to support clinical decision-making for patients seen at the institute's clinic, including decisions on bone marrow transplant donors and immunosuppression treatments. The contract does not have a...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for a Comprehensive IBMF Sequencing Panel valued at $48,000 on August 13, 2019, with completion by August 12, 2020. Work is performed in Chicago, Illinois. This firm fixed price purchase order procures sequencing panel services for biomedical research.</p>
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed-price purchase order contract worth $37,080.00 to the University of Chicago, a private, non-profit educational institution, for the detection of inherited (germline) gene mutations. The contract has a completion date of March 20, 2025 and was awarded on March 21, 2024. No set-aside designation was used. The University of Chicago has previously received prime...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for $31,999.79 on December 15, 2016, to provide scientific support services to the NHLBI Division of Intramural Research. The order is firm fixed price with no set-aside designation. Work is performed in Chicago, Illinois. The period of performance is one year, with ultimate completion on December 14, 2017.</p>